Comparative results of endoluminal gastroplasty and @entity1104 for the treatment of XXXX .

@entity1 @entity2749 @entity6715 @entity548 @entity391 @entity519 @entity354 @entity1104 @entity356
BACKGROUND: Transoral endoluminal gastroplasty (EG) by the Bard Endocinch device is available for the treatment of @entity354 ( @entity354 ). This study assessed the early (<or=12 months) outcomes in @entity1 undergoing EG performed by one gastroenterologist compared with another set of @entity1 referred by the same gastroenterologist for @entity1104 ( @entity1104 ) at a foregut surgery center. METHODS: From June 2000 to July 2002, 87 consecutive @entity1 cared for by a single gastroenterologist were diagnosed with refractory @entity354 and underwent either EG (n = 47) or referral for @entity1104 (n = 40). Preoperative evaluation included symptom assessment, pH studies, and motility studies. Outcomes were assessed by symptomatic improvement and dependence on anti-acid medications. Data analyzed by chi-square or Mann-Whitney tests are reported as mean +/- SEM. RESULTS: Preoperative symptom duration, @entity6715 ( @entity6715 ) score, % time pH < 4, and @entity2749 were statistically similar in both treatment groups. The follow-up times for EG and @entity1104 groups were 7.3 +/- 0.9 and 8 +/- 0.4 months, respectively. Of EG @entity1 , 94% were available for follow-up, and all @entity1104 @entity1 had follow-up data. Overall, 66% of @entity1 were satisfied with EG as compared to 93% after @entity1104 (p = 0.1). Postoperative PPI/motility agent use was 32% for EG and 13% for @entity1104 (p = 0.03). Identifiable causes of EG failure were premature procedure termination due to @entity519 or @entity548 (three @entity1 ), intractable @entity391 (two @entity1 ), and delayed @entity356 (five @entity1 ). Three EG @entity1 subsequently had @entity1104 within 6 months of the procedure. CONCLUSIONS: @entity1104 offers greater reduction in medication use than EG, as well as more durable @entity1 satisfaction. Benefits of EG may include short-term symptomatic improvement while considering definitive surgical management.
